Inflammatory Biomarkers, Death, and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL Study-Reference-Cited by-同舟云学术

Inflammatory Biomarkers, Death, and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL Study

Author:

Zamani Payman¹,Schwartz Gregory G.²,Olsson Anders G.³,Rifai Nader⁴,Bao Weihang⁵,Libby Peter⁶,Ganz Peter⁷,Kinlay Scott⁶⁸,

Affiliation:

1. Cardiovascular Division, University of California, San Diego, CA

2. Cardiology Division, Veterans Affairs Medical Center and University of Colorado, Denver, CO

3. Faculty of Health Sciences, University of Linköping, Linköping, Sweden

4. Children's Hospital Boston and Harvard Medical School, Boston, MA

5. Pfizer Pharmaceuticals Group, New York, NY

6. Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

7. Cardiovascular Division, San Francisco General Hospital and University of California, San Francisco, CA

8. Cardiovascular Division, Veterans Affairs Boston Healthcare System, West Roxbury, Harvard Medical School, Boston, MA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

5. Special Patient Populations;Clinical Lipidology;2024